世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035677

気管支拡張症治療薬の世界市場(2023-2027)

TechNavio

Global Bronchiectasis Drugs Market 2023-2027

発刊日 2023/06/02

言語英語

体裁PDF/168ページ

ライセンス/価格168ページ

0000035677

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

気管支拡張症治療薬市場は、2022年から2027年の間に3億2,601万米ドル成長し、予測期間中に9.98 %のCAGRで加速すると予測されています。気管支拡張症治療薬市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場を牽引しているのは、関連リスク因子の症例数の増加、低コストの適応外ジェネリック医薬品の入手可能性、老年人口の急増です。

調査範囲

  • 市場セグメント
    ➣ 製品別
      ◇ 抗生物質
      ◇ 去痰薬
      ◇ その他
    ➣ 流通チャネル別
      ◇ オフライン
      ◇ オンライン
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

本調査では、気管支拡張症に対する意識の高まりが、今後数年間の気管支拡張症治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、呼吸器疾患の診断の進歩や標的治療に対する需要の高まりは、市場の大きな需要につながるでしょう。

気管支拡張症治療薬市場に関するレポートは、次の分野をカバーしています。

  • 気管支拡張症治療薬市場の規模
  • 気管支拡張症治療薬市場の予測
  • 気管支拡張症治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、気管支拡張症治療薬市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Akorn Operating Co LLC
    ➣ Amneal Pharmaceuticals Inc.
    ➣ Aurobindo Pharma Ltd.
    ➣ Bayer AG
    ➣ Boehringer Ingelheim International GmbH
    ➣ Dr Reddys Laboratories Ltd.
    ➣ Endo International Plc
    ➣ GlaxoSmithKline Plc
    ➣ Hikma Pharmaceuticals Plc
    ➣ Lupin Ltd., Neopharma Corp.
    ➣ Pfizer Inc.
    ➣ Reckitt Benckiser Group Plc
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.
    ➣ Virtus Pharmaceuticals LLC
    ➣ Wockhardt Ltd.
    ➣ Zydus Lifesciences Ltd.

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global bronchiectasis drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global bronchiectasis drugs market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Antibiotics - Market size and forecast 2022-2027
Exhibit 34: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)
6.4 Expectorants - Market size and forecast 2022-2027
Exhibit 38: Chart on Expectorants - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Expectorants - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Expectorants - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Expectorants - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Product
Exhibit 46: Market opportunity by Product ($ million)
Exhibit 47: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 50: Chart on Comparison by Distribution Channel
Exhibit 51: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 52: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 56: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product / Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 Akorn Operating Co LLC
Exhibit 115: Akorn Operating Co LLC - Overview
Exhibit 116: Akorn Operating Co LLC - Product / Service
Exhibit 117: Akorn Operating Co LLC - Key offerings
12.5 Amneal Pharmaceuticals Inc.
Exhibit 118: Amneal Pharmaceuticals Inc. - Overview
Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 120: Amneal Pharmaceuticals Inc. - Key news
Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus
12.6 Aurobindo Pharma Ltd.
Exhibit 123: Aurobindo Pharma Ltd. - Overview
Exhibit 124: Aurobindo Pharma Ltd. - Product / Service
Exhibit 125: Aurobindo Pharma Ltd. - Key offerings
12.7 Bayer AG
Exhibit 126: Bayer AG - Overview
Exhibit 127: Bayer AG - Business segments
Exhibit 128: Bayer AG - Key news
Exhibit 129: Bayer AG - Key offerings
Exhibit 130: Bayer AG - Segment focus
12.8 Boehringer Ingelheim International GmbH
Exhibit 131: Boehringer Ingelheim International GmbH - Overview
Exhibit 132: Boehringer Ingelheim International GmbH - Business segments
Exhibit 133: Boehringer Ingelheim International GmbH - Key news
Exhibit 134: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 135: Boehringer Ingelheim International GmbH - Segment focus
12.9 Dr Reddys Laboratories Ltd.
Exhibit 136: Dr Reddys Laboratories Ltd. - Overview
Exhibit 137: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 138: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 139: Dr Reddys Laboratories Ltd. - Segment focus
12.10 Endo International Plc
Exhibit 140: Endo International Plc - Overview
Exhibit 141: Endo International Plc - Business segments
Exhibit 142: Endo International Plc - Key news
Exhibit 143: Endo International Plc - Key offerings
Exhibit 144: Endo International Plc - Segment focus
12.11 GlaxoSmithKline Plc
Exhibit 145: GlaxoSmithKline Plc - Overview
Exhibit 146: GlaxoSmithKline Plc - Business segments
Exhibit 147: GlaxoSmithKline Plc - Key news
Exhibit 148: GlaxoSmithKline Plc - Key offerings
Exhibit 149: GlaxoSmithKline Plc - Segment focus
12.12 Hikma Pharmaceuticals Plc
Exhibit 150: Hikma Pharmaceuticals Plc - Overview
Exhibit 151: Hikma Pharmaceuticals Plc - Business segments
Exhibit 152: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 153: Hikma Pharmaceuticals Plc - Segment focus
12.13 Lupin Ltd.
Exhibit 154: Lupin Ltd. - Overview
Exhibit 155: Lupin Ltd. - Product / Service
Exhibit 156: Lupin Ltd. - Key news
Exhibit 157: Lupin Ltd. - Key offerings
12.14 Neopharma Corp.
Exhibit 158: Neopharma Corp. - Overview
Exhibit 159: Neopharma Corp. - Product / Service
Exhibit 160: Neopharma Corp. - Key news
Exhibit 161: Neopharma Corp. - Key offerings
12.15 Pfizer Inc.
Exhibit 162: Pfizer Inc. - Overview
Exhibit 163: Pfizer Inc. - Product / Service
Exhibit 164: Pfizer Inc. - Key news
Exhibit 165: Pfizer Inc. - Key offerings
12.16 Reckitt Benckiser Group Plc
Exhibit 166: Reckitt Benckiser Group Plc - Overview
Exhibit 167: Reckitt Benckiser Group Plc - Business segments
Exhibit 168: Reckitt Benckiser Group Plc - Key offerings
Exhibit 169: Reckitt Benckiser Group Plc - Segment focus
12.17 Viatris Inc.
Exhibit 170: Viatris Inc. - Overview
Exhibit 171: Viatris Inc. - Business segments
Exhibit 172: Viatris Inc. - Key news
Exhibit 173: Viatris Inc. - Key offerings
Exhibit 174: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 175: Inclusions checklist
Exhibit 176: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 177: Currency conversion rates for US$
13.4 Research methodology
Exhibit 178: Research methodology
Exhibit 179: Validation techniques employed for market sizing
Exhibit 180: Information sources
13.5 List of abbreviations
Exhibit 181: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global bronchiectasis drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Expectorants - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Expectorants - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Expectorants - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Expectorants - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Product ($ million)
Exhibits47: Data Table on Market opportunity by Product ($ million)
Exhibits48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits49: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. - Overview
Exhibits112: AbbVie Inc. - Product / Service
Exhibits113: AbbVie Inc. - Key news
Exhibits114: AbbVie Inc. - Key offerings
Exhibits115: Akorn Operating Co LLC - Overview
Exhibits116: Akorn Operating Co LLC - Product / Service
Exhibits117: Akorn Operating Co LLC - Key offerings
Exhibits118: Amneal Pharmaceuticals Inc. - Overview
Exhibits119: Amneal Pharmaceuticals Inc. - Business segments
Exhibits120: Amneal Pharmaceuticals Inc. - Key news
Exhibits121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits122: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits123: Aurobindo Pharma Ltd. - Overview
Exhibits124: Aurobindo Pharma Ltd. - Product / Service
Exhibits125: Aurobindo Pharma Ltd. - Key offerings
Exhibits126: Bayer AG - Overview
Exhibits127: Bayer AG - Business segments
Exhibits128: Bayer AG - Key news
Exhibits129: Bayer AG - Key offerings
Exhibits130: Bayer AG - Segment focus
Exhibits131: Boehringer Ingelheim International GmbH - Overview
Exhibits132: Boehringer Ingelheim International GmbH - Business segments
Exhibits133: Boehringer Ingelheim International GmbH - Key news
Exhibits134: Boehringer Ingelheim International GmbH - Key offerings
Exhibits135: Boehringer Ingelheim International GmbH - Segment focus
Exhibits136: Dr Reddys Laboratories Ltd. - Overview
Exhibits137: Dr Reddys Laboratories Ltd. - Business segments
Exhibits138: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits139: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits140: Endo International Plc - Overview
Exhibits141: Endo International Plc - Business segments
Exhibits142: Endo International Plc - Key news
Exhibits143: Endo International Plc - Key offerings
Exhibits144: Endo International Plc - Segment focus
Exhibits145: GlaxoSmithKline Plc - Overview
Exhibits146: GlaxoSmithKline Plc - Business segments
Exhibits147: GlaxoSmithKline Plc - Key news
Exhibits148: GlaxoSmithKline Plc - Key offerings
Exhibits149: GlaxoSmithKline Plc - Segment focus
Exhibits150: Hikma Pharmaceuticals Plc - Overview
Exhibits151: Hikma Pharmaceuticals Plc - Business segments
Exhibits152: Hikma Pharmaceuticals Plc - Key offerings
Exhibits153: Hikma Pharmaceuticals Plc - Segment focus
Exhibits154: Lupin Ltd. - Overview
Exhibits155: Lupin Ltd. - Product / Service
Exhibits156: Lupin Ltd. - Key news
Exhibits157: Lupin Ltd. - Key offerings
Exhibits158: Neopharma Corp. - Overview
Exhibits159: Neopharma Corp. - Product / Service
Exhibits160: Neopharma Corp. - Key news
Exhibits161: Neopharma Corp. - Key offerings
Exhibits162: Pfizer Inc. - Overview
Exhibits163: Pfizer Inc. - Product / Service
Exhibits164: Pfizer Inc. - Key news
Exhibits165: Pfizer Inc. - Key offerings
Exhibits166: Reckitt Benckiser Group Plc - Overview
Exhibits167: Reckitt Benckiser Group Plc - Business segments
Exhibits168: Reckitt Benckiser Group Plc - Key offerings
Exhibits169: Reckitt Benckiser Group Plc - Segment focus
Exhibits170: Viatris Inc. - Overview
Exhibits171: Viatris Inc. - Business segments
Exhibits172: Viatris Inc. - Key news
Exhibits173: Viatris Inc. - Key offerings
Exhibits174: Viatris Inc. - Segment focus
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations

この商品のレポートナンバー

0000035677

TOP